ClinicalTrials.Veeva

Menu
C

Clinical Research Alliance Inc | Lake Success, NY

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Irinotecan
Etrumadenant
Amrubicin
Oxaliplatin
Domvanalimab
GFH009
Ifinatamab
Selinexor
Lurbinectedin
Leucovorin

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 5 total trials

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer (IDeate-Lung02)

This study was designed to compare the efficacy and safety of I-DXd with treatment of physician's choice in participants with relapsed small cell lun...

Enrolling
Small Cell Lung Cancer
Drug: Topotecan
Drug: Amrubicin

The purpose of this study is to look at the efficacy and safety of Irinotecan liposome injection in combination with other approved drugs used for ca...

Active, not recruiting
Metastatic Adenocarcinoma of the Pancreas
Drug: Leucovorin
Drug: Gemcitabine

A multicenter, open-label Phase 2b study of selinexor (KPT-330) in participants with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL)...

Enrolling
Diffuse Large B-cell Lymphoma
Drug: Selinexor

SLS009 (formerly GFH009) is a potent and highly selective CDK9 inhibitor. In this study the safety, tolerability, and antitumor activity of single ag...

Enrolling
Hematologic Malignancies
Drug: venetoclax
Drug: SLS009

This randomized phase 2 open-label study will evaluate the safety and efficacy of zimberelimab (AB122) monotherapy, domvanalimab (AB154) in combinati...

Active, not recruiting
Squamous Non Small Cell Lung Cancer
Nonsquamous Non Small Cell Lung Cancer
Drug: Zimberelimab
Drug: Domvanalimab

Trial sponsors

Arcus Biosciences logo
Daiichi Sankyo logo
Ipsen logo
Karyopharm Therapeutics logo
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems